Sensors-based monitoring and treatment approaches for in-stent restenosis

Ying Yi1, Bo Wang2, Changping Li3

  • 1School of Mechanical Engineering and Electronic Information, China University of Geosciences, Wuhan, China.

Insights

In-stent restenosis (ISR) is a common complication after stenting for cardiovascular disease (CVD). This review examines the latest monitoring and treatment technologies for ISR, aiming to improve future stent systems.

Area of Science:

  • Biomedical Engineering
  • Cardiovascular Research
  • Medical Device Technology

Background:

  • Cardiovascular disease (CVD) involves arterial narrowing due to plaque, often treated with stents.
  • Stent deployment can cause inflammation, leading to in-stent restenosis (ISR), a major cause of death.
  • Early detection and monitoring of ISR are crucial for effective treatment.

Purpose of the Study:

  • To review current technologies for monitoring and treating ISR.
  • To identify potential issues and offer suggestions for existing ISR technologies.
  • To encourage the development of advanced stent systems with improved electromechanical performance, size, functionality, and reliability.

Main Methods:

  • Literature review of recent advancements in ISR monitoring and treatment.
  • Analysis of potential challenges and limitations of current technologies.
  • Synthesis of findings to propose future research directions.

Main Results:

  • Identified key technologies for ISR monitoring and treatment.
  • Highlighted challenges including inflammation, tissue overgrowth, and detection difficulties.
  • Presented suggestions for enhancing stent systems.

Conclusions:

  • Advanced stent systems are needed to address ISR effectively.
  • Future research should focus on improving stent electromechanical properties, size, functionality, and reliability.
  • Enhanced monitoring and early diagnosis are critical for managing ISR and improving patient outcomes.

Related Concept Videos

Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
35
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
23
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
16
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
23
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
488